Category: Health

action, analysis, analytics, approval, approved, business, Business Analysis, cannabidiol, cannabis, cbd, claim, compliance, Concentrates & Extracts, consumer, Coronavirus, COVID, COVID-19, cultivation, drug, Edibles & Processing, enforcement, extraction, farm bill, FD&C act, FDA, Federal, government, growing, Health, industry, lab, law, legal, legalization, legalize, legislation, letter, license, marijuana, market, medical, medicine, New, product, Product Development, Quality, regulation, regulations, regulatory, research, retail, safety, state, test, Testing, thc, threaten, U.S. Food and Drug Administration, unapproved, unsubstantiated, warning, wellness

FDA Warning Letters: Stop Claiming CBD Prevents COVID

FDA Warning Letters: Stop Claiming CBD Prevents COVID

Once again, the U.S. Food and Drug Administration (FDA) has issued a number of warning letters to companies selling hemp-derived cannabidiol (CBD) […]

analysis, analytics, aspergillus, assay, business, cannabis, cbd, CGMP, compliance, consumer, contaminate, contaminated, contamination, cultivation, dispensary, E. coli, Federal, government, growing, harmful, Health, hemp, immunocompromised, industry, inhale, lab, laboratories, Laboratories & Analytics, laboratory, labs, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, microbiology, Milan Patel, mildew, moisture, mold, multiplex, pathogen, PathogenDX, patient, petri, product, Quality, RC - Cannabis Analysis, recreational, regulation, regulations, regulatory, retail, safety, salmonella, Soapbox, state, stringent, test, Testing, thc

The Need for More Stringent Testing in Cannabis

The Need for More Stringent Testing in Cannabis

As the demand for legal cannabis continues to rise and more states come online, it is imperative to enact more rigorous and […]

analysis, analytics, business, cannabis, compliance, consumer, CQC, CQCExpo, department, Dispensaries & Retail, Edibles & Processing, FDA, Federal, government, growing, Health, industry, ingredient, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, of, Operations, PA, pennsylvania, product, Quality, recall, recalling, recalls, regulation, regulations, regulatory, retail, safety, state, test, vape, vaping

Pennsylvania Recalls Vape Products

Pennsylvania Recalls Vape Products

The Pennsylvania Department of Health sent emails back in December to registered medical cannabis patients, notifying them of a safety review being […]

BMJ Paediatrics Open, cannabis oil, cbd, Centre for Psychedelic Research and Nueropsychophamacology, epilepsy, epileptic seizures, Health, Imperial College London, London, medical cannabis, medical CBD, Medical Marijuana, News, seizures, whole-plant, whole-plant cannabis oil, world

Whole-Plant Cannabis Extract Reduces Epileptic Seizures By 86% in Small Study

A small study of children with treatment-resistant epilepsy has found that whole-plant cannabis therapies reduced seizures by 86 percent, according to research […]

8, analysis, analytics, ASTM, business, Business Analysis, cannabis, cbd, compliance, Concentrates & Extracts, consumer, Delta, delta 8, delta-8 THC, Dispensaries & Retail, extraction, FDA, Federal, government, growing, Health, industry, international, lab, laboratories, Laboratories & Analytics, laboratory, labs, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, Pharmacopeia, product, Product Development, public, Quality, RC - Cannabis & Hemp Testing Solutions, recreational, regulation, regulations, regulatory, retail, risk, safety, state, syntehtic, Testing, thc, U.S., USP

Nonprofits Focus Lens on Delta-8-THC

Nonprofits Focus Lens on Delta-8-THC

On December 2, ASTM International, released a whitepaper called “Delta-8-Tetrahydrocannabinol and the Need to Develop Standards to Protect Safety of Consumers.” On the […]